Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (6337)	11/24/1998 5:21:00 PM
From: VLAD	Respond to of 9523

Well it looks like Pfizer has FINALLY admitted that it is dangerous for men with cardiac disease to use Viagra as it has announce that it is relabeling Viagra. This admission I believe will be a green flag for the lawyers to jump on the class action lawsuit bandwagon.

To: Anthony Wong who wrote (6337)	11/24/1998 5:41:00 PM
From: Anthony Wong	Respond to of 9523

Pfizer's Zoloft Effective for Obsessive-Compulsive Kids Bloomberg News November 24, 1998, 4:47 p.m. ET Pfizer's Zoloft Effective for Obsessive-Compulsive Kids Chicago, Nov. 24 (Bloomberg) -- Pfizer Inc.'s depression drug Zoloft is a safe and effective treatment for children with obsessive-compulsive disorder, a new study shows. Although the drug is widely used for adults with obsessive- compulsive disorder, known as OCD, this is the first large clinical trial in children and adolescents. OCD affects about one in 200 children, causing persistent and irrational worries that trigger repetitive behavior like hand washing to alleviate the concerns. Dr. John S. March from Duke University Medical Center in Durham, North Carolina, and his colleagues gave the drug or placebo to 187 patients for 12 weeks. The superiority of Zoloft was seen for most patients at about the third week of treatment, with 42 percent on the drug ''very much or much improved,'' compared with 26 percent on placebo. The average patient remained mildly ill even after taking Zoloft, the researchers said, recommending a combination of drug therapy and psychotherapy for children with the disease. Side effects, including insomnia, nausea, agitation and tremor, also were significantly more common among treated patients. ''Although current treatments are not generally curative, given a correct diagnosis and skillful treatment most children and adolescents with OCD will improve considerably,'' they said. The study, sponsored by New York-based Pfizer, appears in tomorrow's Journal of the American Medical Association. The U.S. Food and Drug Administration is pushing pharmaceutical companies to test products in children since most new drugs get to the market without conclusive proof of safety and effectiveness for younger users. Doctors nonetheless prescribe the drugs for kids because newer products often are considered superior. Eli Lilly & Co.'s Prozac, SmithKline Beecham Plc's Paxil and Forest Laboratories Inc.'s Celexa, also marketed by Warner- Lambert Co., all work in similar ways to Zoloft and together dominate the $8.4 billion worldwide market for depression drugs. --Michelle Fay Cortez in Ithaca, New York (607) 272-1174, through